Skip to main content
. Author manuscript; available in PMC: 2019 Mar 26.
Published in final edited form as: Dig Dis Sci. 2018 Jun 4;63(10):2703–2713. doi: 10.1007/s10620-018-5142-0

Table 1.

Demographic characteristics of inflammatory bowel disease (IBD) cases and controls by country of recruitment

Crohn’s disease
Ulcerative colitis
Control
China n = 113 India n = 25 USA n = 192 China n = 51 India n = 65 USA n = 151 China n = 173 India n = 104 USA n = 302
Female 38.1% 24.0% 62.5% 60.8% 44.6% 67.6% 49.1% 23.1% 71.5%
Age at questionnaire 27.5 29.8 37.1 34.3 33.5 42.5 29.1 45.7 36.8
Year, median, min–max 18–50 18–65 18–82 19–60 18–65 20–76 18–67 20–74 18–76
Duration of IBD at questionnaire 1.9 1.5 11.0 2.0 1.9 8.7 N/A N/A N/A
Year, median, min-max 0–12.7 0–14.2 0–49.0 0–12.0 0–17.6 0–46.3
Age at IBD diagnosis 26.0 28.4 25.0 32.0 28.5 29.2 N/A N/A N/A
Year, median, min–max 13–77 17–51 5–73 16–56 15–64 10–70
 ≤12 0 0 5.2% 0 0 3.3%
 13–17 9.7% 4.0% 15.6% 2.0% 4.6% 5.3%
 18–25 40.7% 24.0% 33.3% 29.4% 36.9% 31.1%
 26–39 40.7% 64.0% 28.7% 37.2% 33.9% 37.8%
 ≥40 8.9% 8.0% 17.2% 31.4% 24.6% 22.5%
Calendar year of IBD diagnosis 2015 2015 2005 2014 2014 2006 N/A N/A N/A
Median, min–max 2003–2016 2002–2017 1966–2016 2003–2017 1997–2017 1969–2016
 ≤1970 0 0 1.0% 0 0 0.7%
 1971–1980 0 0 7.3% 0 0 4.0%
 1981–1990 0 0 10.4% 0 0 10.6%
 1991–2000 0 0 18.8% 0 3.1% 14.6%
 2001–2010 13.3% 12.0% 36.5% 7.8% 18.5% 37.1%
 ≥2011 86.7% 88.0% 26.0% 92.2% 78.4% 33.1%
Any family history of IBD 7.1% 12.0% 40.1% 3.9% 7.7% 40.4% N/Aa N/A N/A
Proportion matched (N matched/ total)b 107/113 25/25 55/219 46/51 62/65 39/151 154/173 97/104 125/302
Relationship to case N/A N/A N/A N/A N/A N/A
 Parent 1.2% 30.8% 4.0%
 Offspring 2.3% 5.8% 4.3%
 Sibling 76.3% 17.3% 15.6%
 Partner/spouse 4.6% 29.8% 14.2%
 Other relative 1.7% 6.7% 0.7%
 Friend 2.9% 2.9% 2.6%
 Independently recruited 11.0% 6.7% 58.6%
a

The prevalence of IBD family history for controls is not listed, as it would not reflect the prevalence of family history among individuals without inflammatory bowel disease in the source or target population, due to the recruiting mechanism of the present study where cases refer their family or friend without IBD to serve as controls

b

All participants contributed to the main analysis. The subset of matched case-control pairs contributed to the match case–control analysis

HHS Vulnerability Disclosure